Ras-Erk MAPK signaling controls many of the principal pathways involved in 25 metazoan cell motility, drives metastasis of multiple cancer types and is targeted in 26
Introduction 41
The mitogen-activated protein kinase (MAPK) Ras-Erk signaling axis plays important 42 roles in cell migration, cancer metastasis, cell proliferation and survival (Eblen, 2018) . 43
Ras GTPases function as molecular switches by cycling between an inactive and active 44 state. Their function in cell motility is linked to localization to the plasma membrane, 45 which is mediated by farnesylation (Cox et al., 1992) . At the plasma membrane, Ras is 46 locally activated by guanine-nucleotide exchange factors (GEFs). In turn, Ras activates 47 the Raf-Mek-Erk signaling cascade which regulates cell migration (Chernyavsky et al., 48 2005; Shi et al., 2019) . In proximity of the cell membrane, Ras activation can be 49 mediated by diverse mechanisms, including receptor tyrosine kinase (RTK) signaling, 50 integrin activation and calcium (Ca 2+ ) influx (Giehl et al., 2000; Rosen et al., 1994; 51 Schlaepfer et al., 1994) . 52
In cancer cells, the RTK Met (also termed c-Met or hepatocyte growth factor 53 receptor/HGFR) promotes cell migration and metastasis upon binding its ligand, 54 hepatocyte growth factor (Hgf, Scatter Factor/SF) (Webb et al., 1998) . Activated Met 55 recruits Ras-GEFs, which locally activate Ras, leading to Erk phosphorylation and cell 56 motility (Hartmann et al., 1994; Wang et al., 2002) . Additionally, voltage-gated Ca 2+ 57 channels (VGCCs) mediate Ca 2+ influx which activates Ca 2+ -sensing proteins locally 58 at the plasma membrane (Dolmetsch et al., 2001; Rosen et al., 1994) . In the context of 59 cell migration, Ca 2+ influx activates calmodulin (CaM) and downstream kinases, which 60 impacts cytoskeleton organization and cell motility by regulating actin dynamics 61 through the Ras-Erk pathway (Li et al., 2004; Lundberg et al., 1998) . Despite the central 62 roles played by MAPK signaling in immune responses (Stupack et al., 2000) , the impact 63 of Ras-Erk signaling on the diverse immune cell functions has only started to be 64 T. gondii-infected DCs, with a non-significant impact on the base-line motility of DCs 116 ( Fig. 1C; Fig. S1C ). Mek antagonism non-significantly impacted DC invasion by T. 117 gondii (Fig. S1D, E) . 118
To determine the respective roles of Erk1 and Erk2 in DC hypermotility, we 119 transduced DCs with lentivirus encoding an eGFP reporter and shRNA targeting erk1 120 (shErk1) or erk2 (shErk2) mRNA or non-expressed mRNA (shLuc). First, the knock 121 down efficiency of shErk1 and shErk2 was quantified. DCs exhibited significantly reduced levels of Erk1 and Erk2 mRNA ( Fig. 1D ) and 123 protein ( Fig. 1E ), respectively, related to mock/shLuc-transduced DCs. Next, the 124 motility of transduced parasitized DCs was analyzed ( Fig. 1F, G) . Importantly, gene 125 silencing of both erk1 and erk2 significantly reduced hypermotility in T. gondii-infected 126 DCs and had a non-significant impact on baseline motility (Fig. 1H ). From these data, 127
we conclude that challenge of DCs with T. gondii is accompanied by a rapid 128 phosphorylation of Erk that underlies T. gondii-mediated migratory activation of DCs. 129 phosphorylation was observed upon VGCC antagonism with both nifedipine and 140 CPCPT in T. gondii-infected DCs ( Fig. 2A) . VGCC inhibition non-significantly 141 impacted on baseline Erk phosphorylation in unchallenged DCs (Fig. S2A ). Because 142 motility-related Ras signaling is strongly associated to localized farnesylated-Ras 143 activity at the plasma membrane (Charest et al., 2010; Sasaki et al., 2004) , we 144 pharmacologically blocked plasma membrane Ras activity. Hence, the Ras 145 farnesylation inhibitor salirasib significantly inhibited Erk phosphorylation in T. gondii-146 infected DCs (Fig. 2B) , with a non-significant impact on baseline Erk phosphorylation 147 ( Fig. S2B ) or T. gondii invasion (Fig. S2C ). Conversely, VGCC agonism with Bay K, 148 a structural analog of nifedipine with a positive ionotropic effect, led to elevated Erk 149 phosphorylation, which was inhibited by salirasib treatment (Fig. 2C ). Importantly, 150 hypermotility was abrogated by Ras antagonism (Fig. 2D, E CaMkII significantly reduced T. gondii-induced Erk phosphorylation ( Fig. 2F) . 158
However, a significant reduction in Erk phosphorylation was also observed in 159 unchallenged DCs upon CaM inhibition, but not CaMkII inhibition ( Fig S2B) , 160 indicating implication of CaM in baseline phosphorylation of Erk. Non-significant 161 effects were observed on T. gondii invasion ( Fig. S2C ). Importantly, CaM and CaMkII 162 antagonism inhibited hypermotility of Toxoplasma-infected DCs (Fig. 2G, H) . A non-163 significant reduction of baseline motility was also noted in unchallenged DCs upon 164 broader impact of CaM on intracellular Ca 2+ homeostasis and a more selective effect of 166 CaMkII on Ras and Raf ( Fig S2B) (Illario et al., 2003) . 167
Together, these data indicate that L-type VGCC-CaV1.3 signal transduction 168 occurs via the CaM-CaMkII-Ras pathway in parasitized DCs, with subsequent 169 phosphorylation of Erk and an impact on DC migration. 170 171
Hgf-Met signaling promotes DC motility via Ras activation and Erk 172 phosphorylation 173
We recently reported the implication of the non-receptor tyrosine kinase Fak in DC 174 hypermotility (Olafsson et al., 2019) . However, receptor tyrosine kinases (RTKs) also 175 play central roles in cell migration and metastasis (Lemmon and Schlessinger, 2010) . 176
Because aberrantly activated RTK Met mediates metastasis in a number of cancers 177 (Benvenuti and Comoglio, 2007; Webb et al., 1998) , we investigated the expression of 178
Met and its ligand Hgf in DCs challenged with T. gondii. Kinetics analyses showed that 179
DCs upregulated the transcription of met and hgf mRNAs shortly after T. gondii 180 challenge ( Fig. S3A, B ), motivating further functional investigation. 181
First, we investigated the impact of Met activation with recombinant Hgf (rHgf) 182 on Erk phosphorylation and DC motility. Indeed, treatment with rHgf induced Erk 183 phosphorylation in unchallenged DCs (Fig. 3A) . Further, rHgf treatment stimulated 184 motility in both unchallenged and T. gondii-challenged DCs (Fig. 3B) . Importantly, T. 185 gondii-induced Erk phosphorylation was significantly inhibited upon treatment with the 186 Met inhibitor su11274 (targeting submembrane Met phosphorylation) and was not 187 rescued by rHgf treatment (Fig. 3C ). Moreover, inhibition of Met phosphorylation 188 inhibited DC hypermotility, with a non-significant impact on DC baseline motility (Fig. 189 of secreted Hgf in supernatants, related to unchallenged DCs (Fig. 3F ). Because Ras 191 acts downstream of Met in its activation of Erk (Wang et al., 2002) and Ras inhibition 192 inhibited hypermotility ( Fig. 2E ) and Erk phosphorylation ( Fig. 2B ), we investigated 193 the impact of salirasib treatment on rHgf-mediated Erk phosphorylation. Similar to its 194 inhibitory effect on VGCC-mediated Erk phosphorylation, salirasib treatment 195 significantly inhibited rHgf-mediated Erk phosphorylation (Fig. 3G). 196 In absence of elevated Hgf secretion upon T. gondii challenge and because T. Taken together, the data show that Met-Ras signaling is activated in DCs upon 205 T. gondii infection, with an impact on motility via phosphorylation of Erk. Further, our 206 data suggest that, in parasitized DCs, Met is activated by both its ligand Hgf and via 207 tyrosine kinase-mediated transactivation. 208
209

Gene silencing of met inhibits hypermotility of T. gondii-infected DCs 210
To determine the role of Met in T. gondii-induced hypermigration, we applied a gene 211 silencing approach in primary DCs. First, we analyzed Met protein expression in DCs 212 by flow cytometry (Fig. S4A, B ). Consistent with met transcription data, signal 213 corresponding to Met protein was significantly elevated in CD11c + DCs infected by T. 214 corresponding to plasma membrane-associated Met and total Met, compared with non-216 infected by-stander DCs (Fig. 4A ). This indicated a selective upregulation of Met in 217 parasite-invaded DCs. 218
Next, we silenced met mRNA expression with lentivirus encoding an eGFP 219 reporter and shRNA targeting met mRNA (shMet) or non-target control (shLuc). First, 220
we confirmed that DCs transduced with shMet exhibited significantly reduced met 221 mRNA ( Fig. 4B, Fig S4C) and Met total protein ( Fig. 4C ), relative to shLuc transduced 222
DCs. Finally, Met-silenced T. gondii-challenged DCs were subjected to motility 223 analyses ( Fig S4D) . Importantly, gene silencing of met abolished hypermotility in T. 224 gondii-infected DCs (Fig. 4D , E), in line with data of pharmacological antagonism of 225 Met ( Fig 3E) . Altogether, these data show that Met signaling is activated in T. gondii-226
infected DCs with an impact on motility. 227
229
Discussion 230
In the present study we investigated the putative role of MAPK Erk1/2 (Erk) in T. 231 gondii-induced hypermigration of primary DCs. We report that T. Our data show that VGCC-CaM-CaMkII-Ras signaling mediate migratory 253 activation of DCs upstream of Erk. Previously, we showed that the onset of the 254 hypermigratory phenotype in DCs depends on live intracellular parasites and the 255 discharge of T. gondii secretory organelles, independently of TLR-MyD88 signaling or 256 chemotaxis (Fuks et al., 2012; Lambert et al., 2006; Olafsson et al., 2018; Sangare et 257 al., 2019; Weidner et al., 2013) . However, TLR-MyD88 signaling and chemotactic 258 stimuli can also activate Erk. Specifically, in T. gondii-infected macrophages, both 259 TLR-MyD88-dependent and a strong component of TLR-MyD88-independent Erk 260 activation has been described (Kim et al., 2006) . However, T. gondii-induced 261 hypermigration is fully maintained in MyD88-deficient DCs (Lambert et al., 2006; 262 Olafsson et al., 2018) . Similarly, hypermigration is independent of chemotactic stimuli 263 (but can act synergistically with chemotaxis upon stimulation) (Fuks et al., 2012; 264 Mek cascade phosphorylates Erk, which drives migratory activation in DCs. The data 330
show that T. gondii orchestrates the migratory activation of parasitized DCs through 331 the Ras-Erk signaling node, which in turn is activated via tyrosine kinase signaling, 332 integrins and GABA/Ca 2+ ion channel activation (Kanatani et al., 2017; Olafsson et al., 333 2019) . Our data also provide a molecular basis for the mesenchymal-to-amoeboid 334 transition (MAT) and hypermigration of parasitized DCs. Interestingly, amoeboid 335 motility is a feature of metastasizing cells and the signaling in parasitized DCs is 336 consonant with emerging paradigms of signaling in metastatic cells (Lambert et al., 337 2017 Technology, Denmark), aligned and ligated in a self-inactivating lentiviral vector 376 (pLL3.7) containing a CMV-driven eGFP reporter and a U6 promoter upstream of 377 cloning restriction sites (HpaI and XhoI) ( Table S1 ). Lentivirus production was done 378 using lipofectamine transfection. Briefly, shLuc, shMet, shErk1 or shErk2 vectors were (Table S2) Proteins were separated on 10% SDS-PAGE gels followed by transfer to 438 polyvinylidene difluoride Immobilon membranes (Millipore). Phospho-Erk was 439 detected using a phospho-Erk antibody (clone 4695P, Cell Signaling), total Erk was 440 detected using an Erk antibody (clone 4370S, Cell Signaling) and Gapdh was detected 441 with (clone ABS16, Millipore Conflict of interest statement. The authors declare that the research was conducted in 460 the absence of any commercial or financial relationships that could be construed as a 461 potential conflict of interest. 462 463 -
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pf5. A. Erk phosphorylation in unchallenged DCs ± nifedipine (50 µM) or CPCPT (10 µM) treatment 2 hpi. Bar graph shows mean (± SEM) phosphorylated Erk1 and Erk2 protein related to Gapdh. Expression of unchallenged DCs was set to 1. Images show representative blots used for quantification from 1 experiment (n=3 biological replicates from independent blots). B. Erk phosphorylation in unchallenged DCs ± salirasib (100 µM), w7 (25 µM) or sto-609 (sto., 50 µM) treatment 2 hpi. Bar graph shows mean (± SEM) phosphorylated Erk1 and Erk2 protein related to Gapdh. Expression of unchallenged DCs was set to 1. Images show representative blots used for quantification from 1 experiment (n=3 biological replicates from independent blots). C. T. gondii infection frequency of DCs cultured in cm ± salirasib (sal.,100 µM), w7 (25 µM) or sto-609 (sto., 50 µM). Histograms show gates used to define T. gondii (GFP+)-infected cells in unchallenged (grey fill) and T. gondii-challenged (red fill) DCs and are representative of 3 experiments. Bar graph shows mean percentage (± SEM) of GFP+ cells (n=3). Asterisks (*) indicate significant difference, ns: non-significant difference: One-way ANOVA, Tukey's HSD post-hoc test (A and C), Unpaired t-test (B).
Figure S3. Met and hgf expression in T. gondii-challenged DCs, impact of Fak inhibition on Erk phosphorylation in unchallenged DCs and infection frequencies.
A. Fold change Met mRNA expression in T. gondii-challenged DCs at 2, 6, 12 and 24 hpi. Bar graph shows mean expression (± SEM) related to gapdh (2 -ΔCt ) and unchallenged DCs (2 -ΔΔCt , n=3 independent experiments). B. Fold change Hgf mRNA expression in T. gondii-challenged DCs at 2, 6, 12 and 24 hpi. Bar graph shows mean expression (± SEM) related to gapdh (2 -ΔCt ) and unchallenged DCs (2 -ΔΔCt , n=3 independent experiments). C. Erk phosphorylation in unchallenged DCs ± pf228 (10 µM) or pf5 (10 µM) treatment 2 hpi. Bar graph shows mean (± SEM) phosphorylated Erk1 and Erk2 protein related to Gapdh. Expression of unchallenged DCs was set to 1. Images show representative blots used for quantification from 1 experiment (n=3 biological replicates from independent blots). D. T. gondii infection frequency of DCs cultured in cm ± pf228 (10 µM) or pf5 (10 µM). Histograms show gates used to define T. gondii (GFP+)-infected cells in unchallenged (grey fill) and T. gondii-challenged (red fill) DCs and are representative of 3 experiments. Bar graph shows mean percentage (± SEM) of GFP + cells (n=3). ns: non-significant difference: One-way ANOVA, Holm-Sidak's multiple comparisons test (C) or Tukey's HSD post-hoc test (D). 
